Why the study?
Does ETB receptor activation modulate thrombin-induced NO release and vascular tone in rat aorta?
Does ETB receptor activation modulate thrombin-induced NO release and vascular tone in rat aorta?
Thrombin-induced endothelium-dependent vasodilation is indirect and requires ETB receptor-coupled NO release, suggesting a mechanism for increased vasomotor tone in injured vessels.
ETB blockade may blunt thrombin-induced relaxation in rodent vessels; leaves open relevance to human endothelial injury or vasomotor tone.
The role of endothelin (ET) receptors in thrombin-induced modulation of vascular tone was evaluated by direct measurement of ET-1 and ET receptor-coupled nitric oxide (NO) release and developed isometric tension in thrombin-treated aortic rings. Here we report that rapid release of ET-1 and subsequent ETB receptor activation are required for production of the potent vasodilator NO by thrombin-stimulated aorta. Thrombin-induced NO release is ablated by pretreatment with ETB receptor antagonists or after ET receptor desensitization by repeated stimulation with ET-1. Thrombin-induced relaxation of precontracted vessels was abrogated in the presence of ETB receptor antagonists and, in contrast, marked contraction to thrombin was observed. These data indicate that the endothelium-dependent vasodilator activity previously attributed to thrombin is indirect and requires ETB receptor-coupled NO release and suggest that ET receptor modulation of thrombin-induced vascular tone may contribute to the increased vasomotor tone observed in diseased and mechanically injured vessels.
No takes yet. Share an insight, caveat, or question.
Magazine et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: